Skip to main content
Top
Published in: Rheumatology International 1/2012

01-01-2012 | Original Article

The spectrum of thyroid disorders in systemic lupus erythematosus

Authors: Kundan Kumar, Alakes Kumar Kole, Partha Sarathi Karmakar, Alakendu Ghosh

Published in: Rheumatology International | Issue 1/2012

Login to get access

Abstract

To study the spectrum of thyroid disorders in systemic lupus erythematosus (SLE). Hundred SLE patients as per American Rheumatology Association(ARA) classification criteria underwent clinical examination, including assessment of disease activity (SLEDAI) and laboratory evaluation for serum triiodothyronine (T3),free thyroxine (FT4), thyroid stimulating hormone (TSH), antithyroperoxidase (TPO) antibody and antithyroglobulin (TG) antibody. Hundred age- and sex-matched apparently healthy individuals served as control. Thirty-six (36%) lupus patients had thyroid dysfunction when compared to 8 (8%) of controls and all of them were women. Primary hypothyroidism was the commonest dysfunction in 14 (14%), while subclinical hypothyroidism and subclinical hyperthyroidism was seen in 12 (12%) and 2 (2%), respectively. Eight (8%) had isolated low T3 consistent with sick euthyroid syndrome. Eighteen (50%) of thyroid dysfunction were autoimmune in nature (autoantibody positive) and rest 18 (50%) were non-autoimmune. Euthyroid state with the elevation of antibodies alone was seen in 12 (12%) of the lupus patients. In contrast, only 5 (5%) of controls had primary hypothyroidism and 3 (3%) had subclinical hypothyroidism, while none had hyperthyroidism. SLEDAI score and disease duration were compared between lupus patients with thyroid dysfunction to those with normal thyroid function. A statistically significant association was found between SLEDAI and thyroid dysfunction of sick euthyroid type.SLE disease duration had no statistically significant association with thyroid dysfunction. Prevalence of thyroid autoantibodies in lupus patients was 30% when compared to 10% of controls. Ninety-six (96%) of the SLE patients were ANA positive, while 4 (4%) of them were ANA negative but were anti-Sm antibody positive. There were no suggestions of any other autoimmune endocrine diseases like diabetes or Addison’s disease (clinically and on baseline investigations) in our lupus cohort and hence no further work up was done for these diseases. Thyroid disorders are frequent in SLE and are multifactorial with a definite higher prevalence of hypothyroidism as well as thyroid autoantibodies.
Literature
1.
go back to reference White RG, Williams E (1961) Lymphadenoid goiter and syndrome of systemic lupus erythematosus. Lancet I:368–373 White RG, Williams E (1961) Lymphadenoid goiter and syndrome of systemic lupus erythematosus. Lancet I:368–373
2.
go back to reference Hijmans W, Doniach D, Roitt IM, Holborow EJ (1961) Serological overlap between lupus erythematosus, rheumatoid arthritis, and thyroid autoimmune disease. Br Med J 2:909–914PubMed Hijmans W, Doniach D, Roitt IM, Holborow EJ (1961) Serological overlap between lupus erythematosus, rheumatoid arthritis, and thyroid autoimmune disease. Br Med J 2:909–914PubMed
3.
go back to reference Turnbridge WM, Evered DC, Hall R et al (1977) The spectrumof thyroid disease in community. The Wickhamsurvey. Clin Endocrinol 7:41–93 Turnbridge WM, Evered DC, Hall R et al (1977) The spectrumof thyroid disease in community. The Wickhamsurvey. Clin Endocrinol 7:41–93
4.
go back to reference Goh KL, Wang F (1986) Thyroid disorders in systemic lupus erythematosus. Ann Rheum Dis 45:579–583PubMed Goh KL, Wang F (1986) Thyroid disorders in systemic lupus erythematosus. Ann Rheum Dis 45:579–583PubMed
5.
go back to reference Miller FW, Moore GF, Weintraub BD, Steinberg AD, Burman KD (1993) Thyroid stimulating and thyrotropin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalities. Thyroid 1:229–234 Miller FW, Moore GF, Weintraub BD, Steinberg AD, Burman KD (1993) Thyroid stimulating and thyrotropin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematosus having thyroid function abnormalities. Thyroid 1:229–234
6.
go back to reference Tsai RT, Chang TC, Wang CR, Chuang CY, Chen CY (1993) Thyroid disorders in Chinese patients with systemic lupus erythematosus. Rheumatol Int 13:9–13PubMed Tsai RT, Chang TC, Wang CR, Chuang CY, Chen CY (1993) Thyroid disorders in Chinese patients with systemic lupus erythematosus. Rheumatol Int 13:9–13PubMed
7.
go back to reference Park DJ, Cho CJ, Lee SH, Park SH, Kim HY (1995) Thyroid disorders in Korean patients with systemic lupus erythematosus. Scand J Rheumatol 24:13–17PubMed Park DJ, Cho CJ, Lee SH, Park SH, Kim HY (1995) Thyroid disorders in Korean patients with systemic lupus erythematosus. Scand J Rheumatol 24:13–17PubMed
8.
go back to reference Pyne D, Isemberg DA (2002) Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 61:70–77PubMed Pyne D, Isemberg DA (2002) Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 61:70–77PubMed
9.
go back to reference Kakehasi AM, Dias VN, Duarte JE, Lanna CCD, de Carvalho MAP (2006) Thyroid abnormalities in systemic lupus erythematosus: a study in 100 Brazilian patients. Rev Bras Reumatol 46:375–479 Kakehasi AM, Dias VN, Duarte JE, Lanna CCD, de Carvalho MAP (2006) Thyroid abnormalities in systemic lupus erythematosus: a study in 100 Brazilian patients. Rev Bras Reumatol 46:375–479
10.
go back to reference Porkodi R et al (2004) Thyroid dysfunction in SLE and rheumatoid arthritis. J Indian Rheumatol Assoc 12:88–90 Porkodi R et al (2004) Thyroid dysfunction in SLE and rheumatoid arthritis. J Indian Rheumatol Assoc 12:88–90
11.
go back to reference Appenzeller S, Pallone Ana T, Natalin Ricardo A, Costallat Lilian T (2009) L: prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumtol 15:117–119 Appenzeller S, Pallone Ana T, Natalin Ricardo A, Costallat Lilian T (2009) L: prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumtol 15:117–119
12.
go back to reference Perez EB, Kraus A, Lopez G, Cifuentes M, Alarcon-Segovia D (1995) Autoimmune thyroid disease in primary Sjögren’s syndrome. Am J Med 99:480–484PubMed Perez EB, Kraus A, Lopez G, Cifuentes M, Alarcon-Segovia D (1995) Autoimmune thyroid disease in primary Sjögren’s syndrome. Am J Med 99:480–484PubMed
13.
go back to reference Dent GR, Edward OM (1978) Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome. Clin Endocrinol 9:215–219 Dent GR, Edward OM (1978) Autoimmune thyroid disease and the polymyalgia rheumatica-giant cell arteritis syndrome. Clin Endocrinol 9:215–219
14.
go back to reference Roitt IM, Doniach D, Campbell PN, Hudson RV (1956) Auto-antibodies in Hashimoto’s disease (lynphadenoid goiter); preliminary communications. Lancet 271:820–821PubMed Roitt IM, Doniach D, Campbell PN, Hudson RV (1956) Auto-antibodies in Hashimoto’s disease (lynphadenoid goiter); preliminary communications. Lancet 271:820–821PubMed
15.
go back to reference Kochupillai N, Goswami R (2000) J Assoc Physicians India 48(Suppl):53–66 Kochupillai N, Goswami R (2000) J Assoc Physicians India 48(Suppl):53–66
16.
go back to reference Weetman AP, Walport MJ (1987) The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 26:359–361PubMed Weetman AP, Walport MJ (1987) The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 26:359–361PubMed
17.
go back to reference Vianna JL, Haga HJ, Asherson RA, Swana G, Hughes GR (1991) A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol 18:1193–1195PubMed Vianna JL, Haga HJ, Asherson RA, Swana G, Hughes GR (1991) A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol 18:1193–1195PubMed
18.
go back to reference Rodrigues LH, Cataggio PM (1989) Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognized association. Ann Rheum Dis 48:424–427 Rodrigues LH, Cataggio PM (1989) Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognized association. Ann Rheum Dis 48:424–427
19.
go back to reference Abraham Z, Rozenbaum M, Feuerman EJ, Kinarty A, Lahat N (1994) Adolescent systemic lupus erythematosus and Graves’ disease. Clin Exp Rheumatol 12:90–91PubMed Abraham Z, Rozenbaum M, Feuerman EJ, Kinarty A, Lahat N (1994) Adolescent systemic lupus erythematosus and Graves’ disease. Clin Exp Rheumatol 12:90–91PubMed
20.
go back to reference Boey ML, Fong PH, Lee JSC, Ng WY, Thai AC (1993) Autoimmune thyroid disease in SLE in Singapore. Lupus 2:51–54PubMed Boey ML, Fong PH, Lee JSC, Ng WY, Thai AC (1993) Autoimmune thyroid disease in SLE in Singapore. Lupus 2:51–54PubMed
21.
go back to reference Bermudez F, Surks MI, Oppenheimer JH (1975) High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab 41:27–40PubMed Bermudez F, Surks MI, Oppenheimer JH (1975) High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab 41:27–40PubMed
22.
go back to reference Chow CC, Mak TW, Chan CH, Cockram CS (1995) Euthyroid sick syndrome in pulmonary tuberculosis before and after treatment. Ann Clin Biochem 32:385–391PubMed Chow CC, Mak TW, Chan CH, Cockram CS (1995) Euthyroid sick syndrome in pulmonary tuberculosis before and after treatment. Ann Clin Biochem 32:385–391PubMed
23.
go back to reference Phillips RH, Valente WA, Caplan ES, Connor TB, Wiswell JG (1984) Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome. J Trauma 24:116–119PubMed Phillips RH, Valente WA, Caplan ES, Connor TB, Wiswell JG (1984) Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome. J Trauma 24:116–119PubMed
24.
go back to reference Eber B, Schumacher M, Langsteger W, Zweiker R, Fruhwald FM, Pokan R et al (1995) Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 86:152–156PubMed Eber B, Schumacher M, Langsteger W, Zweiker R, Fruhwald FM, Pokan R et al (1995) Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 86:152–156PubMed
25.
go back to reference Burr WA, Griffiths RS, Black EG, Hoffenberg RA, Meinhold H, Wenzel KW (1975) Serum triiodothyronine and reverse triiodothyronine concentrations after surgical operations. Lancet 2:1277–1279PubMed Burr WA, Griffiths RS, Black EG, Hoffenberg RA, Meinhold H, Wenzel KW (1975) Serum triiodothyronine and reverse triiodothyronine concentrations after surgical operations. Lancet 2:1277–1279PubMed
26.
go back to reference Chopra IJ, Solomon DH, Chopra U, Young RT, Chua-Teco GN (1974) Alterations in circulating thyroid hormone and thyrotropin in hepatic cirrhosis, evidence of euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab 39:501–511PubMed Chopra IJ, Solomon DH, Chopra U, Young RT, Chua-Teco GN (1974) Alterations in circulating thyroid hormone and thyrotropin in hepatic cirrhosis, evidence of euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab 39:501–511PubMed
27.
go back to reference Finucane JF, Griffiths RS, Black EG, Hall CL (1977) Effects of chronic renal disease on thyroid hormone metabolism. Acta Endocrinol 84:750–758PubMed Finucane JF, Griffiths RS, Black EG, Hall CL (1977) Effects of chronic renal disease on thyroid hormone metabolism. Acta Endocrinol 84:750–758PubMed
28.
go back to reference Burger A, Dinichert D, Nicod P (1976) Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. J Clin Investigation 58:255–259 Burger A, Dinichert D, Nicod P (1976) Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. J Clin Investigation 58:255–259
29.
go back to reference Chopra IJ, Williams DE, Orgiazzi J, Soloman DH (1975) Opposite effects of dexamethasone on serum concentrations of 3, 3′–5′-triiodothyronine (reverse T3) and 3, 3′, 5-triiodothyronine(T3). J Clin Endocrinol Metab 41:911–920PubMed Chopra IJ, Williams DE, Orgiazzi J, Soloman DH (1975) Opposite effects of dexamethasone on serum concentrations of 3, 3′–5′-triiodothyronine (reverse T3) and 3, 3′, 5-triiodothyronine(T3). J Clin Endocrinol Metab 41:911–920PubMed
30.
go back to reference Verhoeven RP, Visser TJ, Docter R (1977) Plasma thyroxine, 3, 3′-5-triiodothyronine and 3, 3′, 5-triiodothyronine during B-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab 44:1002–1005PubMed Verhoeven RP, Visser TJ, Docter R (1977) Plasma thyroxine, 3, 3′-5-triiodothyronine and 3, 3′, 5-triiodothyronine during B-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab 44:1002–1005PubMed
31.
go back to reference Eberhard BA, Laxer RM, Eddy AA, Silverman ED (1991) Presence of thyroid abnormalities in children with systemic lupus erythematosus. J Pediatr 119:277–279PubMed Eberhard BA, Laxer RM, Eddy AA, Silverman ED (1991) Presence of thyroid abnormalities in children with systemic lupus erythematosus. J Pediatr 119:277–279PubMed
32.
go back to reference Kausman D, Isenberg DA (1995) Thyroid autoimmunity in systemic lupus erythematosus. The clinical significance of a fluctuating course. Br J Rheumatol 34:361–364PubMed Kausman D, Isenberg DA (1995) Thyroid autoimmunity in systemic lupus erythematosus. The clinical significance of a fluctuating course. Br J Rheumatol 34:361–364PubMed
33.
go back to reference Magaro M, Zoli A, Altomonte L et al (1992) The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Rheumatol 10:67–70PubMed Magaro M, Zoli A, Altomonte L et al (1992) The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Rheumatol 10:67–70PubMed
34.
go back to reference Kohno Y, Naito N, Saito K, Hoshioka A, Niima H, Nakajima H et al (1989) Anti-thyroid peroxidase antibody in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 75:217–221PubMed Kohno Y, Naito N, Saito K, Hoshioka A, Niima H, Nakajima H et al (1989) Anti-thyroid peroxidase antibody in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 75:217–221PubMed
35.
go back to reference Punzi I, Betterle C (2004) Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71:275–283PubMed Punzi I, Betterle C (2004) Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71:275–283PubMed
Metadata
Title
The spectrum of thyroid disorders in systemic lupus erythematosus
Authors
Kundan Kumar
Alakes Kumar Kole
Partha Sarathi Karmakar
Alakendu Ghosh
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1556-5

Other articles of this Issue 1/2012

Rheumatology International 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.